Rosina M. Critelli
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
First Decompensation Outweighs Portal Vein Thrombosis in cACLD: Molecular Profiling and Derivation of the VAIL Score.
Journal: JHEP reports : innovation in hepatology
Published: April 04, 2026
Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic Scores.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 23, 2026
Intrinsic Tumor Aggressiveness Dictates Hypoxia-Driven Metabolic Programs in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: February 11, 2026
The qEEG-TIPS score: Development of a predictive model for recurrent overt hepatic encephalopathy after elective TIPS.
Journal: JHEP reports : innovation in hepatology
Published: September 11, 2025
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: July 08, 2025
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment.
Journal: Cancers
Published: August 26, 2024
Increase of circulating cell free mitochondrial DNA in amateur boxers after sparring matches.
Journal: Journal of science and medicine in sport
Published: May 22, 2024
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex.
Journal: Biomedicines
Published: May 21, 2024
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.
Journal: Biomedicines
Published: December 02, 2023
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.
Journal: Hepatology communications
Published: July 19, 2023
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.
Journal: Emerging infectious diseases
Published: May 30, 2023
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: July 21, 2022
Last Updated: 09/26/2026